Duloxetine (Loxx 30/Loxx 60) delayed-release capsule is contraindicated in those with known hypersensitivity to duloxetine or any of its ingredients. It is not advocated in hepatic insufficiency, end-stage renal disease, or severe renal impairment (creatinine clearance <30 ml/minute), uncontrolled narrow-angle glaucoma and during lactation if breast-feeding is to be persisted with.
Duloxetine (Loxx 30/Loxx 60) Delayed Release Capsules is not advocated along with MAOIs, serotonin precursors such as tryptophan and thioridazine.
Other Services
Country
Account